A Year Early, Merck Touts Good Kidney Cancer News to Push Rival BMS

A Year Early, Merck Touts Good Kidney Cancer News to Push Rival BMS

Xconomy New York —  Merck could soon join rival Bristol-Myers Squibb in making immunotherapy an option for kidney cancer patients who have never had treatment before. Merck (NYSE: MRK) reported today that its blockbuster pembrolizumab (Keytruda) has hit its marks much earlier than expected in an 861-person Phase 3 study called Keynote-426. Merck tested a […]

150-Year-Old Drug Could Improve Cancer Radiation Therapy

150-Year-Old Drug Could Improve Cancer Radiation Therapy

A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more sensitive to radiation therapy, according to a recent study led by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). The researchers found […]

Relief for cancer patients! 150-year-old drug may improve radiation therapy, says study

Relief for cancer patients! 150-year-old drug may improve radiation therapy, says study

Researchers from Ohio State University (OSU) in the US found that the drug called papaverine, inhibits the respiration of mitochondria, the oxygen-consuming and energy-making components of cells, and sensitises model tumours to radiation. A drug first identified 150 years ago and used as a smooth-muscle relaxant could make tumours more sensitive to radiation therapy, according […]

Novartis to Buy Cancer-Drug Maker Endocyte for $2.1 Billion

Novartis to Buy Cancer-Drug Maker Endocyte for $2.1 Billion

Novartis AG on Thursday said it would buy cancer-drug maker Endocyte Inc. for $2.1 billion, the Swiss pharmaceutical giant’s latest move to refocus on higher-value medicines. Novartis said it would pay $24 a share for the U.S.-based company, which has a focus on prostate cancer—an area with significant unmet medical need. It said the deal […]

Payne updates Lion's Club on cancer drug

Payne updates Lion's Club on cancer drug

WEST POINT — Dr. Kirk Payne of Kalamazoo, Michigan was at the West Point Lion’s Club meeting Wednesday afternoon to inform members of the Greater Valley Area on the advancements in cancer screening and treatment, specifically touching on a development that happened this month. The U.S. Food and Drug Administration, Payne said, recently approved expanded […]

Vast leukemia dataset could help researchers match therapies to patients

After years of work, researchers are releasing a massive dataset detailing the molecular makeup of tumor cells from more than 500 patients with an aggressive blood cancer called acute myeloid leukemia (AML). The dataset includes how hundreds of individual patients’ cells responded to a broad panel of drugs in laboratory screens. It is the largest […]

A 150-year-old drug might improve radiation therapy for cancer

A 150-year-old drug might improve radiation therapy for cancer

Columbus, Ohio – A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more sensitive to radiation therapy, according to a recent study led by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). […]

AI allows 'dynamic dosing' for cancer drugs

AI allows 'dynamic dosing' for cancer drugs

Share this Article You are free to share this article under the Attribution 4.0 International license. Researchers have harnessed a powerful artificial intelligence platform to successfully treat a patient with advanced cancer, completely halting disease progression. The development represents a big step forward in personalized medicine, they say. In this clinical study, researchers gave a […]